Hróbjartsson, Asbjørn

Reporting methods of blinding in randomized trials assessing nonpharmacological treatments

Boutron, I., Guittet, L., Estellat, C., Moher, D., Hróbjartsson, A., & Ravaud, P. (2007) · PLoS Medicine

Statistical Methods in Clinical TrialsMeta-analysis and systematic reviews

Cited by 389

Systematic review adherence to methodological or reporting quality

Pussegoda, K., Turner, L., Garritty, C., Mayhew, A., Skidmore, B., Stevens, A., Boutron, I., Sarkis-Onofre, R., Bjerre, L. M., Hróbjartsson, A., et al. (2017) · Systematic Reviews

Meta-analysis and systematic reviewsClinical practice guidelines implementation

Cited by 322

Efficacy and safety of COVID-19 vaccines

Graña, C., Ghosn, L., Evrenoglou, T., Jarde, A., Minozzi, S., Bergman, H., Buckley, B. S., Probyn, K., Villanueva, G., Henschke, N., et al. (2022) · Cochrane Database of Systematic Reviews

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies

Cited by 310

Impact of blinding on estimated treatment effects in randomised clinical trials: meta-epidemiological study

Moustgaard, H., Clayton, G. L., Jones, H. E., Boutron, I., Jørgensen, L., Laursen, D. R. T., Olsen, M. F., Paludan-Müller, A., Ravaud, P., Savović, J., et al. (2020) · BMJ

Meta-analysis and systematic reviewsStatistical Methods in Clinical Trials

Cited by 300

Ghost Authorship in Industry-Initiated Randomised Trials

Gøtzsche, P. C., Hróbjartsson, A., Johansen, H. K., Haahr, M. T., Altman, D. G., & Chan, A.-W. (2007) · PLoS Medicine

Pharmaceutical industry and healthcareAcademic integrity and plagiarism

Cited by 289

Empirical Evidence of Study Design Biases in Randomized Trials: Systematic Review of Meta-Epidemiological Studies

Page, M. J., Higgins, J. P. T., Clayton, G., Sterne, J. A. C., Hróbjartsson, A., & Savović, J. (2016) · PLOS ONE

Meta-analysis and systematic reviewsStatistical Methods in Clinical Trials

Cited by 284

Using Risk of Bias 2 to assess results from randomised controlled trials: guidance from Cochrane

Flemyng, E., Moore, T. H., Boutron, I., Higgins, J. P., Hróbjartsson, A., Nejstgaard, C. H., & Dwan, K. (2023) · BMJ Evidence-Based Medicine

Meta-analysis and systematic reviewsDelphi Technique in Research

Cited by 264

Considering bias and conflicts of interest among the included studies

Boutron, I., Page, M. J., Higgins, J. P., Altman, D. G., Lundh, A., Hróbjartsson, A., & on behalf of the Cochrane Bias Methods Group (2019) · Cochrane Handbook for Systematic Reviews of Interventions

Meta-analysis and systematic reviewsPharmaceutical industry and healthcare

Cited by 258

Data Extraction Errors in Meta-analyses That Use Standardized Mean Differences

Gøtzsche, P. C., Hróbjartsson, A., Marić, K., & Tendal, B. (2007) · JAMA

Meta-analysis and systematic reviewsStatistical Methods in Epidemiology

Cited by 238

Comparison of descriptions of allocation concealment in trial protocols and the published reports: cohort study

Pildal, J., Chan, A.-W., Hróbjartsson, A., Forfang, E., Altman, D. G., & Gøtzsche, P. C. (2005) · BMJ

Meta-analysis and systematic reviewsStatistical Methods in Clinical Trials

Cited by 209

CONSORT 2025 explanation and elaboration: updated guideline for reporting randomised trials

Hopewell, S., Chan, A.-W., Collins, G. S., Hróbjartsson, A., Moher, D., Schulz, K. F., Tunn, R., Aggarwal, R., Berkwits, M., Berlin, J. A., et al. (2025) · BMJ

Meta-analysis and systematic reviewsStatistical Methods in Clinical Trials

Cited by 205

SPIRIT 2025 explanation and elaboration: updated guideline for protocols of randomised trials

Hróbjartsson, A., Boutron, I., Hopewell, S., Moher, D., Schulz, K. F., Collins, G. S., Tunn, R., Aggarwal, R., Berkwits, M., Berlin, J. A., et al. (2025) · BMJ

Meta-analysis and systematic reviewsStatistical Methods in Clinical Trials

Cited by 171

Placebo effect studies are susceptible to response bias and to other types of biases

Hróbjartsson, A., Kaptchuk, T. J., & Miller, F. G. (2011) · Journal of Clinical Epidemiology

Pain Management and Placebo EffectStatistical Methods in Clinical Trials

Cited by 150

CONSORT 2025 statement: Updated guideline for reporting randomised trials

Hopewell, S., Chan, A.-W., Collins, G. S., Hróbjartsson, A., Moher, D., Schulz, K. F., Tunn, R., Aggarwal, R., Berkwits, M., Berlin, J. A., et al. (2025) · PLOS Medicine

Meta-analysis and systematic reviewsDelphi Technique in Research

Cited by 139

ROB-ME: a tool for assessing risk of bias due to missing evidence in systematic reviews with meta-analysis

Page, M. J., Sterne, J. A. C., Boutron, I., Hróbjartsson, A., Kirkham, J. J., Li, T., Lundh, A., Mayo-Wilson, E., McKenzie, J. E., Stewart, L. A., et al. (2023) · BMJ

Meta-analysis and systematic reviewsStatistical Methods in Epidemiology

Cited by 134

An update to SPIRIT and CONSORT reporting guidelines to enhance transparency in randomized trials

Hopewell, S., Boutron, I., Chan, A.-W., Collins, G. S., de Beyer, J. A., Hróbjartsson, A., Nejstgaard, C. H., Østengaard, L., Schulz, K. F., Tunn, R., et al. (2022) · Nature Medicine

Meta-analysis and systematic reviewsStatistical Methods in Clinical Trials

Cited by 127

Association between conflicts of interest and favourable recommendations in clinical guidelines, advisory committee reports, opinion pieces, and narrative reviews: systematic review

Nejstgaard, C. H., Bero, L., Hróbjartsson, A., Jørgensen, A. W., Jørgensen, K. J., Le, M., & Lundh, A. (2020) · BMJ

Pharmaceutical industry and healthcareGlobal Public Health Policies and Epidemiology

Cited by 116

Financial conflicts of interest in systematic reviews: associations with results, conclusions, and methodological quality

Hansen, C., Lundh, A., Rasmussen, K., & Hróbjartsson, A. (2019) · Cochrane Database of Systematic Reviews

Pharmaceutical industry and healthcareMeta-analysis and systematic reviews

Cited by 96

Promoting public access to clinical trial protocols: challenges and recommendations

Chan, A.-W., & Hróbjartsson, A. (2018) · Trials

Academic Publishing and Open AccessMeta-analysis and systematic reviews

Cited by 84

Constraints on Publication Rights in Industry-Initiated Clinical Trials

Gøtzsche, P. C., Hróbjartsson, A., Johansen, H. K., Haahr, M. T., Altman, D. G., & Chan, A.-W. (2006) · JAMA

Pharmaceutical industry and healthcareEthics in Clinical Research

Cited by 81

Reporting on blinding in trial protocols and corresponding publications was often inadequate but rarely contradictory

Hróbjartsson, A., Pildal, J., Chan, A.-W., Haahr, M. T., Altman, D. G., & Gøtzsche, P. C. (2009) · Journal of Clinical Epidemiology

Meta-analysis and systematic reviewsStatistical Methods in Clinical Trials

Cited by 56

Interventions for the prevention and treatment of COVID-19: a living mapping of research and living network meta-analysis

Boutron, I., Chaimani, A., Devane, D., Meerpohl, J. J., Rada, G., Hróbjartsson, A., Tovey, D., Grasselli, G., & Ravaud, P. (2020) · Cochrane Database of Systematic Reviews

COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 Research

Cited by 41

Control interventions in randomised trials among people with mental health disorders

Faltinsen, E., Todorovac, A., Staxen Bruun, L., Hróbjartsson, A., Gluud, C., Kongerslev, M. T., Simonsen, E., & Storebø, O. J. (2022) · Cochrane Database of Systematic Reviews

Statistical Methods in Clinical TrialsMeta-analysis and systematic reviews

Cited by 40

Influence and management of conflicts of interest in randomised clinical trials: qualitative interview study

Østengaard, L., Lundh, A., Tjørnhøj-Thomsen, T., Abdi, S., Gelle, M. H. A., Stewart, L. A., Boutron, I., & Hróbjartsson, A. (2020) · BMJ

Pharmaceutical industry and healthcareEthics in Clinical Research

Cited by 35